Clarius Group, LLC Abbott Laboratories Transaction History

Clarius Group, LLC

$1.39 Billion
Q2 2024

A detailed history of Clarius Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Clarius Group, LLC holds 11,629 shares of ABT stock, worth $1.31 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

11,629

Previous 12,680 8.29%

Holding current value

$1.31 Million

Previous $1.44 Million 16.17%

% of portfolio

0.09%

Previous 0.1%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	SELL	$100.73 - $112.44 $105,867 - $118,174	-1,051 Reduced 8.29%	11,629 $1.21 Million
Q1 2024 Apr 17, 2024	SELL	$109.52 - $120.96 $244,010 - $269,498	-2,228 Reduced 14.94%	12,680 $1.44 Million
Q4 2023 Jan 29, 2024	BUY	$90.19 - $110.4 $95,871 - $117,355	1,063 Added 7.68%	14,908 $1.64 Million
Q3 2023 Oct 19, 2023	SELL	$95.53 - $114.62 $687,911 - $825,378	-7,201 Reduced 34.22%	13,845 $1.34 Million
Q2 2023 Aug 09, 2023	BUY	$100.78 - $112.29 $112,369 - $125,203	1,115 Added 5.59%	21,046 $2.29 Million
Q1 2023 Apr 17, 2023	SELL	$96.86 - $114.01 $137,734 - $162,122	-1,422 Reduced 6.66%	19,931 $2.02 Million
Q4 2022 Jan 25, 2023	SELL	$95.06 - $111.52 $35,172 - $41,262	-370 Reduced 1.7%	21,353 $2.34 Million
Q3 2022 Oct 24, 2022	BUY	$96.76 - $112.03 $126,271 - $146,199	1,305 Added 6.39%	21,723 $2.1 Million
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $67,264 - $81,300	659 Added 3.34%	20,418 $2.22 Million
Q4 2021 Feb 02, 2022	BUY	$115.53 - $141.46 $94,156 - $115,289	815 Added 4.3%	19,759 $2.78 Million
Q3 2021 Oct 18, 2021	BUY	$116.66 - $129.06 $92,744 - $102,602	795 Added 4.38%	18,944 $2.24 Million
Q2 2021 Aug 06, 2021	SELL	$105.79 - $124.53 $2,115 - $2,490	-20 Reduced 0.11%	18,149 $2.1 Million
Q1 2021 Apr 27, 2021	BUY	$108.84 - $128.23 $100,459 - $118,356	923 Added 5.35%	18,169 $2.18 Million
Q4 2020 Jan 15, 2021	BUY	$105.0 - $114.42 $190,575 - $207,672	1,815 Added 11.76%	17,246 $1.89 Million
Q3 2020 Oct 09, 2020	SELL	$91.64 - $111.29 $13,287 - $16,137	-145 Reduced 0.93%	15,431 $1.68 Million
Q2 2020 Jul 08, 2020	BUY	$76.57 - $98.0 $174,656 - $223,538	2,281 Added 17.16%	15,576 $1.42 Million
Q1 2020 Apr 24, 2020	SELL	$62.82 - $91.86 $8,731 - $12,768	-139 Reduced 1.03%	13,295 $1.05 Million
Q4 2019 Jan 22, 2020	BUY	$78.51 - $87.4 $157 - $174	2 Added 0.01%	13,434 $1.17 Million
Q3 2019 Oct 23, 2019	BUY	$81.84 - $88.74 $101,481 - $110,037	1,240 Added 10.17%	13,432 $1.12 Million
Q2 2019 Aug 02, 2019	BUY	$72.88 - $85.0 $144,083 - $168,045	1,977 Added 19.35%	12,192 $1.03 Million
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $411,292 - $497,252	6,211 Added 155.12%	10,215 $817,000
Q4 2018 Feb 11, 2019	BUY	$65.56 - $74.27 $262,502 - $297,377	4,004 New	4,004 $290,000

Others Institutions Holding ABT

# of Institutions

3,135

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.

Account

Clarius Group, LLC Abbott Laboratories Transaction History